No Data
No Data
Express News | Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend Its Reporting Obligations
Immunome Completes Purchase of AL102, Related Drug Candidate AL101 From Ayala Pharmaceuticals >IMNM
Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome
Ayala Completes Patient Enrollment for Pivotal Desmoid Tumor Study
Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors
Wedbush Raises Immunome's PT to $27 From $19 on Heels of Announced Plans to Acquire AL101, AL102 From Ayala Pharmaceuticals; Keeps Outperform Rating
Lnova OP : Does anyone know about this ticker? Is it pink market ?